CSF Biomarkers in early MS
- Department of Neurology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic
DOI: 10.12751/g-node.74jj3f BROWSE REPOSITORY BROWSE ARCHIVE DOWNLOAD ARCHIVE (ZIP 114 KiB)
Published 17 Mar. 2022 | License Attribution-ShareAlike Version 4.0 International
This repository contains the dataset, upon which the article "IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis" submitted to PLOS ONE in march 2022 was based. The dataset consists of clinical, CSF, serum and MRI findings from 58 patients treated at the MS Centre of the Motol University Hospital between January 2017 and May 2018 and a control group.
Keywords| Neuroscience | Multiple Sclerosis | Biomarkers |
- Petržalka M, Meluzínová E, Libertínová J, Mojžišová H, Hanzalová J, Ročková P, et al. IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis. PLoS One. https://doi.org/tba